Cargando…
Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway
BACKGROUND/AIMS: Combination therapy utilizing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in conjunction with other anticancer agents, is a promising strategy to overcome TRAIL resistance in malignant cells. Recently, parthenolide (PT) has proved to be a promising anticanc...
Autores principales: | Trang, Kieu Thi Thu, Kim, Se-Lim, Park, Sang-Bae, Seo, Seung-Young, Choi, Chung-Hwan, Park, Jin-Kyoung, Moon, Jin-Chang, Lee, Soo-Teik, Kim, Sang-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204686/ https://www.ncbi.nlm.nih.gov/pubmed/25349561 http://dx.doi.org/10.5217/ir.2014.12.1.34 |
Ejemplares similares
-
Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells
por: Liu, Yu Chuan, et al.
Publicado: (2017) -
Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model
por: Kim, In Hee, et al.
Publicado: (2012) -
Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
por: Zhu, Shi Mao, et al.
Publicado: (2019) -
Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
por: Kim, Hyun-Young, et al.
Publicado: (2015) -
The Association of the Activation-Inducible Tumor Necrosis Factor Receptor and Ligand with Lumbar Disc Herniation
por: Park, Moon-Soo, et al.
Publicado: (2007)